February 4, 2011 -- In China, life science VC investing climbed an astonishing 319% in 2010 to break $1 billion. By contrast, venture capital investing in the United States’ life science was flat compared to 2009 levels, showing a dramatic switch in the world’s perceptions of where the future lies for biomedical companies. More details....
